Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now
Read now
Stephen Thornton, David Lisbon, Thomas Lin & Roy Gerona. (2017) Beyond Ketamine and Phencyclidine: Analytically Confirmed Use of Multiple Novel Arylcyclohexylamines. Journal of Psychoactive Drugs 49:4, pages 289-293.
Read now
Read now
P. I. Dargan, H. C. Tang, W. Liang, D. M. Wood & D. T. Yew. (2014) Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice. Clinical Toxicology 52:3, pages 176-180.
Read now
Read now
Anette Kjellgren & Kristoffer Jonsson. (2013) Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet. Journal of Psychoactive Drugs 45:3, pages 276-286.
Read now
Read now
Jennifer E. Shields, Paul I. Dargan, David M. Wood, Malgorzata Puchnarewicz, Susannah Davies & W. Stephen Waring. (2012) Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation. Clinical Toxicology 50:5, pages 438-440.
Read now
Read now
Articles from other publishers (40)
Miroslava Bursová, Tomáš Hložek, Miloš Sokol, Monika Židková & Radomír Čabala. (2023) Methoxetamine and its metabolites: Postmortem determination in body fluids of human cadaver. Journal of Analytical Toxicology.
Crossref
Crossref
Paul Beninger & Jill Maron. (2022) When Still Water Runs Deep: The Complexities of Clinically Repurposing FDA Approved Therapies. Clinical Therapeutics 44:11, pages 1427-1430.
Crossref
Crossref
Mark D. Salter & Naren Gunja. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
381
414
.
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
James H. Ho & Paul I. Dargan. 2018. Critical Care Toxicology. Critical Care Toxicology
1
47
.
Jason Wallach & Simon D. Brandt. 2018. New Psychoactive Substances. New Psychoactive Substances
305
352
.
M T Zanda, P Fadda, S Antinori, M Di Chio, W Fratta, C Chiamulera & L Fattore. (2017) Methoxetamine affects brain processing involved in emotional response in rats. British Journal of Pharmacology 174:19, pages 3333-3345.
Crossref
Crossref
James H. Ho & Paul I. Dargan. 2017. Critical Care Toxicology. Critical Care Toxicology
1439
1484
.
Timothy Fassette & Afton Martinez. (2016) An Impaired Driver Found to be Under the Influence of Methoxetamine. Journal of Analytical Toxicology 40:8, pages 700-702.
Crossref
Crossref
Mary T. Zanda, Paola Fadda, Cristiano Chiamulera, Walter Fratta & Liana Fattore. (2016) Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings. Behavioural Pharmacology 27:6, pages 489-496.
Crossref
Crossref
Samantha J. Coward & Hilary J. Hamnett. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
127
146
.
David M. Wood & Paul I. Dargan. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
44
53
.
Adam R. Winstock, Will Lawn, Paolo Deluca & Rohan Borschmann. (2016) Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and Alcohol Review 35:2, pages 212-217.
Crossref
Crossref
James H. Ho & Paul I. Dargan. 2016. Critical Care Toxicology. Critical Care Toxicology
1
46
.
Santiago Nogué, Miguel Galicia, Marina Parra & Jordi To-Figueras. (2015) Urgencias asociadas al consumo de metoxetamina. Primeras descripciones en España de esta nueva droga. Medicina Clínica 145:9, pages 416-417.
Crossref
Crossref
Santiago Nogué, Miguel Galicia, Marina Parra & Jordi To-Figueras. (2015) Methoxetamine-associated emergencies. First Spanish descriptions of this new drug. Medicina Clínica (English Edition) 145:9, pages 416-417.
Crossref
Crossref
Agnieszka Wiesner, Aleksandra Tyl & Jolanta B. Zawilska. (2015) Metoksetamina – nowy związek psychoaktywny („dopalacz”) o silnym działaniu psychodysleptycznym. Alcoholism and Drug Addiction 28:2, pages 131-138.
Crossref
Crossref
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) New Synthetic Drugs in Addictovigilance. Therapies 70:2, pages 179-189.
Crossref
Crossref
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) Nouvelles drogues de synthèse en addictovigilance. Therapies 70:2, pages 167-178.
Crossref
Crossref
Laura Hondebrink, Johanna J. Nugteren-van Lonkhuyzen, Daan Van Der Gouwe & Tibor M. Brunt. (2015) Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the Poisons Information Centre. Drug and Alcohol Dependence 147, pages 109-115.
Crossref
Crossref
Jolanta B. Zawilska. (2014) Methoxetamine – a novel recreational drug with potent hallucinogenic properties. Toxicology Letters 230:3, pages 402-407.
Crossref
Crossref
Ritva Karinen, Silja Skogstad Tuv, Sidsel Rogde, Mariana Dadalto Peres, Unni Johansen, Joachim Frost, Vigdis Vindenes & Åse Marit Leere Øiestad. (2014) Lethal poisonings with AH-7921 in combination with other substances. Forensic Science International 244, pages e21-e24.
Crossref
Crossref
Laurent Imbert, Alexandra Boucher, Gilles Delhome, Thierry Cueto, Michel Boudinaud, Julie Maublanc, Sylvain Dulaurent, Jacques Descotes, Gérard Lachâtre & Jean-Michel Gaulier. (2014) Analytical Findings of an Acute Intoxication after Inhalation of Methoxetamine. Journal of Analytical Toxicology 38:7, pages 410-415.
Crossref
Crossref
Hamilton Morris & Jason Wallach. (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis 6:7-8, pages 614-632.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging drugs of abuse. Disease-a-Month 60:3, pages 110-132.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging Drugs of Abuse. Emergency Medicine Clinics of North America 32:1, pages 1-28.
Crossref
Crossref
Simon L Hill, Siân C D Harbon, James Coulson, Gillian A Cooper, Gill Jackson, David J Lupton, J Allister Vale & Simon H L Thomas. (2014) Methoxetamine toxicity reported to the National Poisons Information Service: clinical characteristics and patterns of enquiries (including the period of the introduction of the UK's first Temporary Class Drug Order). Emergency Medicine Journal 31:1, pages 45-47.
Crossref
Crossref
Raoul Koning & Raymond Niesink. (2013) Nieuwe Psychoactieve Stoffen (NPS): niets nieuws onder de zon. Verslaving 9:1, pages 47-59.
Crossref
Crossref
A. D. Westwell, A. Hutchings & D. G. E. Caldicott. (2012) The identification and chemical characterization of a new arylcyclohexylamine, methoxetamine, using a novel Emergency Department toxicosurveillance tool. Drug Testing and Analysis 5:3, pages 203-207.
Crossref
Crossref
Savithiri Ratnapalan. (2013) Legal substances and their abuse: Legal highs. Journal of Paramedic Practice 5:1, pages 40-51.
Crossref
Crossref
Maria Wikström, Gunilla Thelander, Maria Dahlgren & Robert Kronstrand. (2013) An Accidental Fatal Intoxication with Methoxetamine. Journal of Analytical Toxicology 37:1, pages 43-46.
Crossref
Crossref
Emuri Abe, Florian Ricard, Philippe Charlier, Geoffroy de la Grandmaison & Jean-Claude Alvarez. (2013) Intoxication non létale par la Méthoxétamine : confirmation analytique à l’aide d’un système d’extraction en ligne Turboflow® couplé à de la LC/MS/MS. Annales de Toxicologie Analytique 25:1, pages 17-25.
Crossref
Crossref
Shaun L. Greene. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
393
409
.
Emuri Abe, Florian Ricard, François Darrouzain & Jean Claude Alvarez. (2012) An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detection. Analytical and Bioanalytical Chemistry 405:1, pages 239-245.
Crossref
Crossref
M. Coppola & R. Mondola. (2012) Methoxetamine: From drug of abuse to rapid-acting antidepressant. Medical Hypotheses 79:4, pages 504-507.
Crossref
Crossref
Gregory G. Davis. (2012) Drug Abuse. Clinics in Laboratory Medicine 32:3, pages 407-414.
Crossref
Crossref
David M. Wood & Paul I. Dargan. (2012) Novel Psychoactive Substances. Therapeutic Drug Monitoring 34:4, pages 363-367.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Supportive & Palliative Care 6:2, pages 289-298.
Crossref
Crossref
David M. Wood, Susannah Davies, Malgorzata Puchnarewicz, Atholl Johnston & Paul I. Dargan. (2011) Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. European Journal of Clinical Pharmacology 68:5, pages 853-856.
Crossref
Crossref
Christopher D. Rosenbaum, Stephanie P. Carreiro & Kavita M. Babu. (2012) Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines. Journal of Medical Toxicology 8:1, pages 15-32.
Crossref
Crossref